Lyocontract

LYOCONTRACT is a specialized CDMO focused on the sterile manufacturing of injectable drugs, both liquid and lyophilized. Its core competency lies in aseptic vial filling and the development and optimization of freeze-drying cycles, supported by in-house analytics and packaging services. Since receiving its manufacturing license in 2012, the company has established itself as a trusted partner for pharmaceutical companies, backed by modern facilities and significant experience in sterile processing. A majority stake was acquired by Lyomark Pharma GmbH in 2017, providing strategic stability while maintaining independent operations.

State-of-the-art aseptic filling and lyophilization (freeze-drying) platform for parenteral drugs in vials, supported by in-house analytical testing and packaging services. Core expertise includes GMP-compliant sterile manufacturing and development/optimization of freeze-drying cycles.

Operates in the highly competitive contract manufacturing space for sterile injectables, competing against large multinational CDMOs (e.g., Lonza, Catalent) and numerous European specialists. Differentiates through a focused expertise in lyophilization, a full-service model with in-house analytics, and a reputation for German engineering quality and regulatory compliance.